A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study

Authors: Shashi N. Kapadia, Judith L. Griffin, Justine Waldman, Nicolas R. Ziebarth, Bruce R. Schackman, and Czarina N. Behrends

Kapadia, S. N., Griffin, J. L., Waldman, J., Ziebarth, N. R., Schackman, B. R., & Behrends, C. N. (2021). A harm reduction approach to treating opioid use disorder in an independent Primary Care Practice: A qualitative study. Journal of General Internal Medicine, 36(7), 1898–1905. https://doi.org/10.1007/s11606-020-06409-6 

​

Telemedicine Increases Access to Buprenorphine Initiation During the COVID-19 Pandemic

Authors: Linda Wang, Jeffrey Weiss, Elizabeth Bogel Ryan, Justine Waldman, Stacey Rubin, and Judy L. Griffin

Wang, L., Weiss, J., Ryan, E. B., Waldman, J., Rubin, S., & Griffin, J. L. (2021). Telemedicine increases access to buprenorphine initiation during the covid-19 pandemic. Journal of Substance Abuse Treatment, 124, 108272. https://doi.org/10.1016/j.jsat.2020.108272 

 

Lowering the Barriers to Medication Treatment for People with Opioid Use Disorder

Authors: Shoshana V. Aronqitz, Czarina Navos Behrends, Margaret Lowenstein, Bruce R. Schackman, and Janet Weiner

Aronowitz, S. V., Behrends, C. N., Lowenstein, M., Schackman, B. R., & Weiner, J. (2022, January 18). Lowering the barriers to medication treatment for people with opioid use disorder. Penn LDI. Retrieved January 12, 2023, from https://ldi.upenn.edu/our-work/research-updates/lowering-the-barriers-to-medication-treatment-for-people-with-opioid-use-disorder/?utm_medium=email&_hsmi=202117277&_hsenc=p2ANqtz-88KG1UgOyLLxNtCIbauQQ_NBcplIYFhLp2FUUzmRudM2HcW8WOVZLWf7hiXRlccFt-jstGk4UmZ2vJyivok3kiiOMvEA&utm_content=202117277&utm_source=hs_email 

 

The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice

Authors: Shashi N. Kapadia, Judith L. Griffin, Justine Waldmna, Nicolas R. Ziebarth, Bruce R. Schackman, and Czarina N. Behrends

Kapadia, S. N., Griffin, J. L., Waldman, J., Ziebarth, N. R., Schackman, B. R., & Behrends, C. N. (2021). The experience of implementing a low-threshold buprenorphine treatment program in a non-urban medical practice. Substance Use & Misuse, 57(2), 308–315. https://doi.org/10.1080/10826084.2021.2012484 

 

Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment During COVID-19

Authors: Ji Eun Chang, Zoe Lindenfeld, Tatiana Thomas, Justine Waldman, and Judy Griffin

Chang, J. E., Lindenfeld, Z., Thomas, T., Waldman, J., & Griffin, J. (2022). Patient characteristics associated with phone versus video telemedicine visits for substance use treatment during COVID-19. Journal of Addiction Medicine, 16(6), 659–665. https://doi.org/10.1097/adm.0000000000000985 

 

Engaging People Experiencing Homelessness in Community Health Worker-Facilitated Telehealth Services in Response to COVID-19

Authors: Judy Griffin, Justine Waldman, and Matt Dankanich

Griffin, J., Waldman, J., & Dankanich, M. (2021). ENGAGING PEOPLE EXPERIENCING HOMELESSNESS IN COMMUNITY HEALTH WORKER-FACILITATED TELEHEALTH SERVICES IN RESPONSE TO COVID-19. Journal of General Internal Medicine, S387–S387. 

 

Implementing Low-threshold Access to Medication for Opioid Use Disorder in a Non-urban Setting: Experiences from REACH Medical

Author: Judy Griffin